SCHEMBL1463130

SCHEMBL1463130

CCS[C@H]1O[C@H](COC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1OC(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS9 O00182 4/20 0.52
▸ LGALS1 P09382 4/20 0.52
▸ LGALS3 P17931 4/20 0.52
▸ LGALS7; LGALS7B P47929 3/20 0.52
▸ MEN1 O00255 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ GAPDH P04406 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ LGALS8 O00214 2/20 0.41
▸ SYNJ2 O15056 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ PTPN1 P18031 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ SLC22A1 O15245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12848097 0.93 LGALS9 (0.55) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL12847759 0.93 LGALS9 (0.55) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL5974144 0.90 LGALS9 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL7251664 0.88 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL16917900 0.88 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL1521440 0.88 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL8346842 0.88 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL16917918 0.88 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL8899505 0.88 LGALS9 (0.54) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL17193904 0.88 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9605050-B2 Glycoprotein synthesis and remodeling by enzymatic transglycosylation UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-03-28 — — US disclosed
US-20170081390-A9 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION UNIVERSITY OF MARYLAND, BALTIMORE 2017-03-23 — — US disclosed
EP-2001358-B1 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION UNIV MARYLAND (US) 2016-07-13 — — EP disclosed
US-20150087811-A1 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION UNIV MARYLAND (US) 2015-03-26 — — US disclosed
US-8900826-B2 Glycoprotein synthesis and remodeling by enzymatic transglycosylation UNIVERSITY OF MARYLAND, BALTIMORE (US) 2014-12-02 — — US disclosed
US-20130131325-A1 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-05-23 — — US disclosed
US-8354247-B2 Glycoprotein synthesis and remodeling by enzymatic transglycosylation UNIVERSITY OF MARYLAND, BALTIMORE (US) 2013-01-15 — — US disclosed
US-20110070607-A1 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-03-24 — — US disclosed
US-7807405-B2 Drug delivery; drug targetting UNIVERSITY OF MARYLAND BALTIMORE, OFFICE OF COMMERCIAL VENTURES AND INTELLECTUAL PROPERTY (US) 2010-10-05 — — US disclosed
EP-2001358-A2 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION University Of Maryland Biotechnology Institute (US) 2008-12-17 — — EP disclosed
US-20080138855-A1 Drug delivery; drug targetting NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-06-12 — — US disclosed
WO-2007133855-A2 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2007-11-22 — — WO disclosed
Send feedback